HDAC2 and breast carcinoma: To further explore whether HDAC2 affected the biological functions of breast cancer cells, we used CRISPR/Cas9 gene editing method to construct a mouse TNBC cell strains (4T-1) that stably knocked out HDAC2 (HDAC2-KO).